attention%20deficit_hyperactivity%20disorder
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the presence of impairing levels of inattention, disorganization and/or hyperactivity-impulsivity.
Symptoms that suggest ADHD include hyperactivity, acting without thinking, inattention/daydreaming, fidgety, restless, excessive talking, aggressive behavior, academic underachievement, disorganized and has difficulty in completing tasks.

Follow Up

  • Initially, monitor on a monthly basis until consistent optimal response is noted
    • Then every 3 months in the 1st year of treatment
  • Subsequent follow-up will depend on patient’s response, adherence to treatment strategy, presence of associated conditions
    • Recommended is at least 2 times a year
  • Monitor treatment outcomes and adverse effects (cardiovascular effects, development of tics or seizures, sexual dysfunction, changes in sleep pattern, worsening behavior, stimulant misuse and diversion) by gathering information from parents, teachers and the child
  • Monitor core symptoms using DSM-5-based ADHD rating scales (eg Vanderbilt ADHD follow-up scales)
  • Re-evaluate the patient when treatment and management plan does not meet desired outcomes
  • Reassess patient at school-leaving age to check for continuity of care into adulthood 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
19 Sep 2016
Sertraline may prevent the onset of depressive disorders after traumatic brain injury (TBI), a randomized trial showed.
23 Jul 2019
Eating healthy foods, especially those following the Mediterranean dietary pattern, or avoiding proinflammatory diet appears to exert a protective effect on the risk of depression, according to a systematic review and meta-analysis.
09 Oct 2016
The use of hormonal contraception increases the risk of subsequent use of antidepressants and a first diagnosis of depression, results of a study show.
01 Dec 2016
Vortioxetine 5-20 mg/day lessens depression and anxiety severity in patients with major depressive disorder (MDD) and high levels of anxiety, as observed in a meta-analysis of 10 randomised, placebo-controlled, 6/8-week trials.